Nike Is Down 32% This Year and Under Investigation by the EEOC. Is NKE a Buy, Sell, or Hold?

Nike’s operating picture remains under pressure: Q3 fiscal 2026 revenue fell 2.7% year over year and net profit margin compressed to 4.8%, down from 12.8% in 2021. Management also expects Q4 sales to decline, with China sales down 10% in the latest quarter and falling for seven straight quarters amid weak demand, excess inventory, tariffs, layoffs, and an EEOC investigation. The stock is down 32% year to date and nearly 76% from its November 2021 peak.

Analysis

Nike is entering a classic brand-to-balance-sheet downgrade: when top-line deterioration collides with margin compression, operating leverage turns against you far faster than investors expect. The market is still likely pricing this as a temporary China hiccup, but the deeper issue is that Nike’s premium positioning is being challenged by a structural shift toward local brands and value-led purchasing, which can suppress mix for multiple cycles rather than quarters.

The second-order risk is that every attempted fix is margin dilutive before it is growth accretive. Inventory cleanup, discounting, layoffs, and marketing reset all help cash conversion in isolation, but together they signal a business that must spend more to defend relevance while taking lower gross profit per unit. That creates a path where EPS can keep falling even if reported revenue stabilizes, because the operating model is losing elasticity.

The near-term catalyst set is asymmetric to the downside: further China weakness, another disappointing guidance update, or continued reputational noise can keep the stock in a lower multiple regime for months. The contrarian case is not that Nike is cheap on current earnings — it may be cheap on peak normalized earnings, but the real question is whether the brand still deserves a premium multiple if it cannot re-accelerate China and regain pricing power. Until that evidence arrives, any bounce is more likely a short-covering rally than a durable re-rating.

The knock-on winner is not necessarily another US sportswear name; it is whoever captures the value-seeker and local-preference consumer in China, plus retailers/distributors with cleaner inventory and better promotional discipline. In the US, weaker Nike demand can also create shelf-space and promotional opportunities for smaller athletic brands, but only if they are not forced into the same discount cycle.

Key Decisions for Investors

• Short NKE on rallies over the next 1-3 weeks; use a 3-6 month horizon. Risk/reward favors downside if China and margin commentary worsen, with a reasonable stop if management shows credible evidence of inventory normalization and channel health.
• Structure a NKE put spread 3-6 months out rather than outright puts. This captures downside from a slow bleed in multiple expansion while reducing theta risk if the stock grinds sideways.
• Pair trade: short NKE vs long a higher-quality athletic/apparel beneficiary with cleaner China exposure and better execution. The relative trade works even if sector sentiment stabilizes, because the issue is company-specific underperformance and margin erosion.
• Avoid buying the dip in SBUX as a China-recovery proxy; the article reinforces that domestic-brand preference is a broader consumer-nationalism headwind. Any rebound in China-facing consumer names should be faded until there is hard evidence of traffic re-acceleration.
• For long-only books, wait for a post-earnings reset before considering NKE. Require either a clear inflection in China sales or a gross margin bottom; absent that, the stock remains a value trap with negative revision risk over the next 2-3 quarters.